Daclizumab Subcutaneous and Hydrochlorothiazide and losartan
Determining the interaction of Daclizumab Subcutaneous and Hydrochlorothiazide and losartan and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: hydrochlorothiazide / losartan
Brand name: Hyzaar
Synonyms: Losartan and Hydrochlorothiazide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Hydrochlorothiazide and methyldopa
- Daclizumab Subcutaneous-Hydrochlorothiazide and metoprolol
- Daclizumab Subcutaneous-Hydrochlorothiazide and moexipril
- Daclizumab Subcutaneous-Hydrochlorothiazide and olmesartan
- Daclizumab Subcutaneous-Hydrochlorothiazide and propranolol
- Daclizumab Subcutaneous-Hydrochlorothiazide and quinapril
- Hydrochlorothiazide and losartan-Dacogen
- Hydrochlorothiazide and losartan-Dacomitinib
- Hydrochlorothiazide and losartan-Dactinomycin
- Hydrochlorothiazide and losartan-Dactinomycin Injection
- Hydrochlorothiazide and losartan-Dactinomycin Intravenous
- Hydrochlorothiazide and losartan-Daklinza